Ethical • Legal • Safe • Accountable AI Operations

Clinical AI Exposure Diagnostic™

Full Diagnostic deliverables:

Nine outputs. Three audiences. One evidence pack.

In four working days you receive a complete board-ready evidence pack structured for three distinct audiences: the board and senior leadership, the DPO and clinical governance team, and the insurer, MDO or CQC inspector who may ask what AI is in use and how it is controlled.

Clinical AI Exposure Diagnostic™ overviewHomepage overview

For the board and leadership

Board Findings Report

BoardPartners

Plain-English leadership summary explaining what was found, why it matters, the top risks and what should happen next. Written for non-technical readers.

One-page RAG Exposure Map

BoardPartners

Single-page board-level visual showing Red, Amber, Green and N/A status for each AI tool across seven governance dimensions. Designed for board minutes.

30-Day Priority Action Plan

BoardSenior Mgmt

Sequenced actions with named owners and required evidence to move from unmanaged to managed AI use within 30 days of delivery.

For the DPO and clinical governance

AI Tool and Use-Case Inventory

DPOClinical Governance

Master register of declared and shadow AI tools: owner, users, purpose, patient-data involvement, approval status and review priority for each.

DPIA Readiness and Patient Data Exposure Note

DPOLegal

High-risk indicators, DPIA status, RoPA and privacy notice gaps, retention and data-flow issues structured for DPO review and decision.

Ambient Scribe Assessment Sheet

DPOCSOClinical Lead

Per-tool evidence status against supplier assurance, data protection, patient transparency, clinical safety and human oversight expectations. Where applicable.

For external review and disclosure readiness

Vendor Data Position and Evidence Tracker

DPOProcurement

Per-supplier tracker covering DPAs, data residency, sub-processors, retention, training-data use, security assurance and international transfer indicators.

MDO, PMI and Insurer Disclosure Readiness Note

InsurerMDORenewals

Governance evidence relevant to insurer renewal questions, MDO indemnity discussions and PMI provider due-diligence requests. Disclosure templates included.

Source and Guidance Mapping Appendix

CQCAuditDPO

Every finding mapped to ICO, CQC, NHS England, MHRA and MDO published guidance, so reviewers can see exactly which expectation each gap relates to.

9

deliverables

Fixed fee £4,500–£6,500 + VAT. Four working days from completed intake. Senior-led delivery by Faisal Ali, CISM, CRISC. Includes a 60-minute board readout.

Book a discovery callEmail ELSA AI